Promoter shareholding remains stable with negligible changes YoY and QoQ, indicating no additional insider confidence in the stock.

Institutional selling is significant with a 0.57% drop QoQ, contrasting with the sector's stable institutional positions, signaling a lack of institutional support for Zydus Wellness.

Public shareholding shows minor increases, but this is insufficient to offset the decline from institutional investors, reflecting a broader trend of selling in the stock.